"This is one of the best firms I have worked together with. The reason for this is specifically Christian Wyss. Their work is highly diligent and they find innovative but market-proven ways on how to reach a desired outcome."

"The team understands to bring regulatory experts and experts in IT law and data protection to the table, ensuring a holistic and consistent advice, acting as a one stop shop."

"A professional and very effective team, they know what they are dealing with and when facing a challenge, they resolve it in the outmost professional manner."

"Dedicated, responsive and professional. They do not waste your time and every exchange is effective and straight to the point."

"The team is notable in being able to provide technical advice on highly complex areas of law while also remaining practical and keeping the client’s interests at heart."

‘Christian Wyss is excellent. Highly responsive, thoughtful, creative and efficient.’

"Wyss is highly experienced and has a pragmatic approach which eases the negotiations with the other party and allows for progression in a lean and efficient manner."

Christian Wyss is "competent and responsive," according to sources. He  frequently assists with transactions and financing mandates in the life sciences sector.

Key practice areas for VISCHER are capital markets, M&A, healthcare, TMT and transport as well as public law, competition and litigation. Among the names to note are Klaus Neff, Stefan Kohler, Rolf Auf Der Maur, Benedict Christ, David Rosenthal and Stefan Rechsteiner as well as Christian Oetiker, Michael Waldner, and Christian Wyss.

Christian Wyss frequently assists with transactions and financing mandates in the life sciences sector. One satisfied client describes him as "very competent, dependable, proactive and able to find new solutions."

The well-established life sciences practice at VISCHER is sought after by a range of players in the industry, including pharmaceutical companies, start-ups and investors. Covering the healthcare, pharmaceutical, biotech and cosmetics sectors, the team handles contentious and non-contentious regulatory and patent matters as well as financing rounds and M&A transactions. Stefan Kohler enjoys a strong reputation among his peers and has experience in IP and technology law. He jointly leads the practice with Basel-based Matthias Staehelin, who is well versed in capital markets, venture capital and agreements in the relevant field. Christian Wyss, also in the Basel office, is noted for his knowledge in R&D, technology transfers and license agreements.

"Christian Wyss stands out as an extremely knowledgable professional. He is always going beyond the basic requirements in order to understand his client’s needs and strives to see problems from their point of view. He takes extreme care to produce results which attend to the current and future needs of his clients."

"VISCHER is highly regarded for its healthcare, TMT and transport practices as well as its expertise in capital markets, M&A, public law, competition and litigation matters. Key at the firm include Stefan Kohler, Rolf Auf der Maur, Benedict Christ, Stefan Rechsteiner and Christian Oetiker. Michael Waldner, Klaus Neff and Christian Wyss are other names to note."

"VISCHER's IP practice handles patent litigation and protection strategies, copyright licensing and agreements for online models and video on demand (VOD) platforms, and trade mark portfolio management. Highlights included team head Stefan Kohler co-ordinating the European market launch of Migros Delica's new coffee capsules compatible with Nespresso machines, and Rolf Auf der Maur successfully defending Swisscom in the first-ever national ISP blocking case. Christian Wyss focuses on due diligence and M&A-related cases."

"VISCHER's team handles asset tokenisation and international blockchain disputes, as well as providing legal compliance training to start-ups and drafting their set-up agreements. Mobile payments and crowdfunding expert Jana Essebier heads the practice, which has acted as a main adviser to the Interchain Foundation on all fintech-related issues, assisted Vreo with the set-up of an in-game video advertising platform, and aced for Bank CIC (Schewiz) AG on the development of its mobile payment processes. Stefan Grieder and Basel-based Christian Wyss are other names to note."

"Clients appreciate VISCHER's 'fast response times, great flexibility' and 'good business sense' when handling cloud-based software as a service offerings, cross-border data security and GDPR issues, and IT sourcing transactions. The team advised Tiko on the business-to-business and customer agreements for its energy consumption optimisation service and is assisting Swisscom AG with various matters following on from representing it in Switzerland's first ISP blocking case. Practice head Rolf Auf der Maur has 'excellent knowledge' and is noted for his 'transparent working methods'. Other work, largely led by Basel-based Christian Wyss, involves third-party collaboration and software licensing agreements for DigitalPK, Skillue and Sympany."

"VISCHER has a strong track record in transactions in the life sciences space, in which it acts for companies, entrepreneurs and investors alike. It is also well versed in advising clients on compliance matters, administrative procedures and other regulatory matters. Stefan Kohler has longstanding experience in the sector and further advises on IP and technology law. He jointly leads the practice alongside Matthias Staehelin in Basel, who is a key contact for M&A, IPOs and financings in this space. Christian Wyss, also in Basel, has considerable knowledge in setting up contracts and assisting start-ups."

Christian Wyss covers a range of matters within the life sciences field, including licensing agreements and acquisitions. He also offers notable strength in financing mandates. One client describes him as "flexible and responsive," adding: "He is adaptable to the situation as needed in negotiations."

"VISCHER's TMT practice has experience of sector-relevant convergence issues, regulatory requirements, online services licensing, outsourcing and transfer agreements. Rolf Auf der Maur successfully represented Swisscom as defendant in the first Swiss ISP-blocking matter brought by film rights holders, while Basel-based Christian Wyss assists Sympany with the review, drafting and negotiation of various different IT agreements with suppliers and outsourcing providers. Netflix, Quadrant and Additiv also feature in the client list."

"VISCHER has core strength in the healthcare, TMT and transport sectors and notable public law expertise, while also fielding strong capital markets, M&A, competition and litigation departments. Key partners include Stefan Kohler, Rolf Auf der Maur, Stefan Rechsteiner, Benedict Christ and Christian Oetiker. Michael Waldner and Christian Wyss are other names to note."

"The intellectual property department at VISCHER covers protective, strategic, transactional and contentious matters in relation to patents, copyright, designs and trade marks. Christian Wyss assisted Balderton Capital with the IP due diligence in preparation for its investment into Sophia Genetics' $30m financing round, while team lead Stefan Kohler advises Philipp Morris on the agreements required for the technological development of reduced-risk tobacco products. Rolf Der Maur, who combines intellectual property law with IT expertise, is another name to note."

"VISCHER is renowned for its expertise in corporate, commercial, transactional, regulatory and patent-related healthcare and biotech matters. Matthias Staehelin assisted Medartis with its initial public offering on the SIX Swiss Exchange, while Stefan Kohler acted for Novo Nordisk Pharma in its appeal against a pricing decision made by the Swiss Federal Office of Public Health concerning the client's type-two diabetes product. Christian Wyss advised Lundbeck on its €905m acquisition of Prexton Therapeutics."

"A client describes Christian Wyss as "practical and knowledgeable" and another adds that "working with him is very easy and his responses are always on time." He acts for clients from the life sciences sector on financing and transactional matters, and assisted JSR Corporation with the Swiss aspects of its acquisition of Selexis. Wyss also advises on regulatory matters, such as research agreements and clinical trials."

"Christian Wyss enters the rankings for the first time on the back of strong client support. One client enthuses that he is 'responsive, knowledgeable, considerate and intelligent.' Another source notes that he is 'careful in listening to the needs of the customer' and is a 'clear communicator.' His work includes assisting T3 Pharmaceuticals with various financing and licence agreements. He has further capabilities advising on acquisitions and collaborative agreements within the life sciences sector."

"Vischer provides transactional, financing, capital markets, product launch and regulatory advice to health and life sciences industry clients and further represents them in contentious matters. The practice assisted JSR Corporation with its acquisition of Selexis and advised Axovant Sciences on its debt financing agreement with Hercules Capital. Stefan Kohler jointly heads the practice with Matthias Staehelin; Christian Wyss is another name to note."

"Vischer has an ‘excellent’ regulatory practice, including compliance and administrative procedures, remarkable IP capabilities and a niche in acting for emerging biotech companies, where it advised GlycoVaxyn and Redvax on their sales to GlaxoSmithKline and Pfizer, respectively. Other clients include AstraZeneca, Novartis, Mattern Pharmaceuticals and IVF Zentren Prof. Zech. Stefan Kohler has ‘very broad knowledge’, including regulatory and IP matters, and is recommended along with Matthias Staehelin and newly promoted partner Christian Wyss."

"Vischer’s ‘highly skilled’ team assisted insurer Sympany with negotiating IT contracts and has been advising Ring Central on data protection and telecoms regulatory matters. Other clients include 3 Plus, Netflix and Swisscom. Rolf Auf der Maur and Christian Wyss are recommended."